男性型脱毛症治療の世界市場レポート 2025年

男性型脱毛症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.5％で33億米ドルに成長します。予測期間における成長は、抜け毛の罹患率の上昇、がん、多嚢胞性卵巣症候群（PCOS）、関節リウマチなどの慢性疾患の流行、抜け毛の悩みに対処する効果的なソリューションへの需要に起因すると考えられます。予測期間における主な動向には、提携、製品承認、投資、研究開発が含まれます。

脱毛症患者の増加は、今後の男性型脱毛症治療市場の成長を牽引すると予測されます。脱毛症（抜け毛）とは、頭皮や身体の他の部分から毛髪が部分的または完全に失われることを指します。脱毛の原因としては、栄養不足、ホルモンの変動、遺伝的素因、ストレスレベルの上昇などが挙げられます。男性型脱毛症の治療では、ホルモン調節、毛包刺激、外科的介入など、さまざまな方法を用いて脱毛を管理し、発毛を促します。例えば、米国を拠点とする団体である毛髪協会が2022年3月に報告したように、世界では約2,100万人の女性と3,500万人の男性が脱毛の影響を受けています。また、英国の政府機関である国民保健サービスによると、2024年には英国で約800万人の女性と650万人の男性が脱毛を経験しています。さらに、年間65万件以上の植毛が行われています。従って、脱毛症例の増加は男性型脱毛症治療市場を推進しています。

男性型脱毛症治療市場の主なプレーヤーは、脱毛に対処するための革新的な薬剤オプションを積極的に開発しています。これらのオプションは、毛包再生の促進、脱毛の原因となるホルモンの阻害、局所治療や経口薬などの新しいデリバリーシステムの利用などのメカニズムをターゲットとしています。例えば、2023年6月、米国のヘルスケア企業であるファイザー社は、12歳以上の重度の円形脱毛症患者を対象とした1日1回投与の経口治療薬であるリトフーロ（リトルシチニブ）のFDA承認を発表しました。LITFULOは、ヤヌスキナーゼ3（JAK3）および肝細胞がんに発現するチロシンキナーゼ（TEC）ファミリーを標的とするキナーゼ阻害剤です。FDAの承認は、ALLEGROフェーズ2b/3試験に基づいており、リツフロ50mgを投与された患者の23％が6ヵ月後に80％以上の頭皮毛髪被覆率を達成したのに対し、プラセボでは1.6％でした。本剤は、著しい脱毛を経験する患者に新たな選択肢を提供し、円形脱毛症治療におけるこれまで満たされていなかったニーズに応えるものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界男性型脱毛症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の男性型脱毛症治療市場：成長率分析
• 世界の男性型脱毛症治療市場の実績：規模と成長, 2019-2024
• 世界の男性型脱毛症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界男性型脱毛症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の男性型脱毛症治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• デバイス
• 世界の男性型脱毛症治療市場薬の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 処方箋
• 店頭
• 世界の男性型脱毛症治療市場性別：、実績と予測, 2019-2024, 2024-2029F, 2034F
• 男
• 女性
• 世界の男性型脱毛症治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 在宅ケア設定
• 皮膚科
• クリニック
• その他のエンドユーザー
• 世界の男性型脱毛症治療市場医薬品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口薬（フィナステリド）
• 外用薬（ミノキシジル）
• ホルモン療法
• 世界の男性型脱毛症治療市場、デバイスの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• レーザー治療装置
• 毛髪移植機器
• 頭皮マイクロピグメンテーションデバイス

第7章 地域別・国別分析

• 世界の男性型脱毛症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の男性型脱毛症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 男性型脱毛症治療市場：競合情勢
• 男性型脱毛症治療市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Daiichi-Sankyo Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sun Pharmaceutical Industries Ltd.
• Allergan Plc
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Fagron Inc.
• Vitabiotics Ltd.
• Cosmo Pharmaceuticals NV
• Aclaris Therapeutics Inc.
• Curallux LLC
• PureTech Health
• Technoderma Medicines Inc.
• Theradome Inc.
• Lexington International
• HCell Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 男性型脱毛症治療市場2029：新たな機会を提供する国
• 男性型脱毛症治療市場2029：新たな機会を提供するセグメント
• 男性型脱毛症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Androgenetic alopecia, also referred to as male-pattern baldness or female-pattern hair loss, is a prevalent form of hair loss affecting both men and women. It is characterized by a gradual thinning of the hair, commonly starting with a receding hairline in men and diffuse thinning over the crown in women. Genetic factors and the presence of androgens, particularly dihydrotestosterone (DHT), play significant roles in this condition.

The primary treatments for androgenetic alopecia include pharmaceuticals and devices. Pharmaceuticals encompass substances used in healthcare, typically medicinal drugs or chemical compounds. These medications are available in both prescription and over-the-counter forms and are utilized by both males and females. They find applications in various end-user industries, including homecare settings, dermatology, clinics, and others.

The androgenetic alopecia treatment market research report is one of a series of new reports from The Business Research Company that provides androgenetic alopecia treatment market statistics, including androgenetic alopecia treatment industry global market size, regional shares, competitors with an androgenetic alopecia treatment market share, detailed androgenetic alopecia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the androgenetic alopecia treatment industry. This androgenetic alopecia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The androgenetic alopecia treatment market size has grown strongly in recent years. It will grow from $2.29 billion in 2024 to $2.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to emphasis on improving patient outcomes and quality of life, increase in the geriatric population, increasing healthcare expenditure.

The androgenetic alopecia treatment market size is expected to see strong growth in the next few years. It will grow to $3.3 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to rising incidence of hair loss, prevalence of chronic diseases such as cancer, polycystic ovary syndrome (PCOS), and rheumatoid arthritis, demand for effective solutions to address hair loss concerns. Major trends in the forecast period include partnerships, product approvals, investments, research and developments.

The increasing incidence of hair loss cases is projected to drive the growth of the androgenetic alopecia treatment market in the future. Alopecia, or hair loss, refers to the partial or complete loss of hair from the scalp or other parts of the body. Causes of hair loss include nutritional deficiencies, hormonal fluctuations, genetic predispositions, and heightened stress levels. Androgenetic alopecia treatments employ various methods, including hormonal regulation, follicle stimulation, and surgical interventions, to manage hair loss and stimulate regrowth. For example, as reported in March 2022 by the Hair Society, an organization based in the US, approximately 21 million women and 35 million men worldwide are affected by hair loss. Additionally, in 2024, according to the National Health Service, a government agency in the UK, around 8 million women and 6.5 million men in the UK experience hair loss. Moreover, over 650,000 hair transplants are performed annually. Hence, the increasing prevalence of hair loss cases propels the androgenetic alopecia treatment market.

Key players in the androgenetic alopecia treatment market are actively developing innovative drug options to address hair loss. These options target mechanisms such as promoting hair follicle regeneration, inhibiting hormones responsible for hair loss, and utilizing novel delivery systems such as topical treatments and oral medications. For instance, in June 2023, Pfizer Inc., a healthcare company based in the US, announced the FDA approval of LITFULO (ritlecitinib), a once-daily oral treatment for individuals aged 12 and above with severe alopecia areata. LITFULO is a kinase inhibitor that targets Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) family of kinases. The FDA approval was based on the ALLEGRO Phase 2b/3 trial, where 23% of patients treated with LITFULO 50mg achieved 80% or more scalp hair coverage after six months, compared to 1.6% with placebo. This solution offers a new option for individuals experiencing significant hair loss, addressing a previously unmet need in alopecia areata treatment.

In April 2023, Marksans Pharma, an India-based pharmaceutical company, acquired a manufacturing facility from Tevapharm India for an undisclosed sum. This strategic acquisition enabled Marksans Pharma to double its existing manufacturing capacity in India and broaden its product range to include tablets, capsules, ointments, liquids, and creams. Teva Pharmaceuticals, based in Israel, provides treatments for androgenetic alopecia.

Major companies operating in the androgenetic alopecia treatment market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eli Lilly and Company, Daiichi-Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Allergan Plc, Aurobindo Pharma Limited, Dr Reddy's Laboratories Ltd., Cipla Limited, Fagron Inc., Vitabiotics Ltd., Cosmo Pharmaceuticals NV, Aclaris Therapeutics Inc., Curallux LLC, PureTech Health, Technoderma Medicines Inc., Theradome Inc., Lexington International, HCell Inc., Follica Inc., Ranbaxy Laboratories Ltd., Apira Science Inc., Freedom Laser Therapy Inc., Histogen Inc.

North America was the largest region in the androgenetic alopecia treatment market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the androgenetic alopecia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the androgenetic alopecia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The androgenetic alopecia treatment market consists of sales of microneedling devices, hair growth vitamins, and supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Androgenetic Alopecia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on androgenetic alopecia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for androgenetic alopecia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The androgenetic alopecia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Pharmaceutical; Device
• 2) By Medication Type: Prescription; Over-The-Counter
• 3) By Gender: Male; Female
• 4) By End-User: Homecare Settings; Dermatology; Clinics; Other End-Users
• Subsegments:
• 1) By Pharmaceutical: Oral Medications ( Finasteride); Topical Medications (Minoxidil); Hormonal Therapy
• 2) By Device: Laser Therapy Devices; Hair Transplant Devices; Scalp Micropigmentation Devices
• Companies Mentioned: Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Eli Lilly and Company; Daiichi-Sankyo Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Androgenetic Alopecia Treatment Market Characteristics

3. Androgenetic Alopecia Treatment Market Trends And Strategies

4. Androgenetic Alopecia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Androgenetic Alopecia Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Androgenetic Alopecia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Androgenetic Alopecia Treatment Market Growth Rate Analysis
• 5.4. Global Androgenetic Alopecia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Androgenetic Alopecia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Androgenetic Alopecia Treatment Total Addressable Market (TAM)

6. Androgenetic Alopecia Treatment Market Segmentation

• 6.1. Global Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical
• Device
• 6.2. Global Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription
• Over-The-Counter
• 6.3. Global Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Male
• Female
• 6.4. Global Androgenetic Alopecia Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Homecare Settings
• Dermatology
• Clinics
• Other End-Users
• 6.5. Global Androgenetic Alopecia Treatment Market, Sub-Segmentation Of Pharmaceutical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Medications (Finasteride)
• Topical Medications (Minoxidil)
• Hormonal Therapy
• 6.6. Global Androgenetic Alopecia Treatment Market, Sub-Segmentation Of Device, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laser Therapy Devices
• Hair Transplant Devices
• Scalp Micropigmentation Devices

7. Androgenetic Alopecia Treatment Market Regional And Country Analysis

• 7.1. Global Androgenetic Alopecia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Androgenetic Alopecia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Androgenetic Alopecia Treatment Market

• 8.1. Asia-Pacific Androgenetic Alopecia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Androgenetic Alopecia Treatment Market

• 9.1. China Androgenetic Alopecia Treatment Market Overview
• 9.2. China Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Androgenetic Alopecia Treatment Market

• 10.1. India Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Androgenetic Alopecia Treatment Market

• 11.1. Japan Androgenetic Alopecia Treatment Market Overview
• 11.2. Japan Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Androgenetic Alopecia Treatment Market

• 12.1. Australia Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Androgenetic Alopecia Treatment Market

• 13.1. Indonesia Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Androgenetic Alopecia Treatment Market

• 14.1. South Korea Androgenetic Alopecia Treatment Market Overview
• 14.2. South Korea Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Androgenetic Alopecia Treatment Market

• 15.1. Western Europe Androgenetic Alopecia Treatment Market Overview
• 15.2. Western Europe Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Androgenetic Alopecia Treatment Market

• 16.1. UK Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Androgenetic Alopecia Treatment Market

• 17.1. Germany Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Androgenetic Alopecia Treatment Market

• 18.1. France Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Androgenetic Alopecia Treatment Market

• 19.1. Italy Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Androgenetic Alopecia Treatment Market

• 20.1. Spain Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Androgenetic Alopecia Treatment Market

• 21.1. Eastern Europe Androgenetic Alopecia Treatment Market Overview
• 21.2. Eastern Europe Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Androgenetic Alopecia Treatment Market

• 22.1. Russia Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Androgenetic Alopecia Treatment Market

• 23.1. North America Androgenetic Alopecia Treatment Market Overview
• 23.2. North America Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Androgenetic Alopecia Treatment Market

• 24.1. USA Androgenetic Alopecia Treatment Market Overview
• 24.2. USA Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Androgenetic Alopecia Treatment Market

• 25.1. Canada Androgenetic Alopecia Treatment Market Overview
• 25.2. Canada Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Androgenetic Alopecia Treatment Market

• 26.1. South America Androgenetic Alopecia Treatment Market Overview
• 26.2. South America Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Androgenetic Alopecia Treatment Market

• 27.1. Brazil Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Androgenetic Alopecia Treatment Market

• 28.1. Middle East Androgenetic Alopecia Treatment Market Overview
• 28.2. Middle East Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Androgenetic Alopecia Treatment Market

• 29.1. Africa Androgenetic Alopecia Treatment Market Overview
• 29.2. Africa Androgenetic Alopecia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Androgenetic Alopecia Treatment Market, Segmentation By Medication Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Androgenetic Alopecia Treatment Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Androgenetic Alopecia Treatment Market Competitive Landscape And Company Profiles

• 30.1. Androgenetic Alopecia Treatment Market Competitive Landscape
• 30.2. Androgenetic Alopecia Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Daiichi-Sankyo Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Androgenetic Alopecia Treatment Market Other Major And Innovative Companies

• 31.1. Sun Pharmaceutical Industries Ltd.
• 31.2. Allergan Plc
• 31.3. Aurobindo Pharma Limited
• 31.4. Dr. Reddy's Laboratories Ltd.
• 31.5. Cipla Limited
• 31.6. Fagron Inc.
• 31.7. Vitabiotics Ltd.
• 31.8. Cosmo Pharmaceuticals NV
• 31.9. Aclaris Therapeutics Inc.
• 31.10. Curallux LLC
• 31.11. PureTech Health
• 31.12. Technoderma Medicines Inc.
• 31.13. Theradome Inc.
• 31.14. Lexington International
• 31.15. HCell Inc.

32. Global Androgenetic Alopecia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Androgenetic Alopecia Treatment Market

34. Recent Developments In The Androgenetic Alopecia Treatment Market

35. Androgenetic Alopecia Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Androgenetic Alopecia Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Androgenetic Alopecia Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Androgenetic Alopecia Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer